Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000960273 | SCV001107234 | benign | not provided | 2023-12-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002400116 | SCV002706515 | likely benign | Cardiovascular phenotype | 2022-03-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003323767 | SCV004029778 | benign | not specified | 2023-07-18 | criteria provided, single submitter | clinical testing |